Inflammatory Bowel Disease Treatment Market

Future Market Insights

Key Insight

The inflammatory bowel disease treatment market is projected to grow from USD 24.1 billion in 2025 to USD 42.0 billion by 2035, at a CAGR of 5.7%. Crohn's Disease will dominate with a 53.6% market share, while amino salicylates will lead the drug class segment with a 28.4% share.

August 04, 2025

Anurag Sharma

250 Pages

Cite this Report

Inflammatory Bowel Disease Treatment Market

https://www.futuremarketinsights.com/reports/inflammatory-bowel-disease-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Amgen
Novartis
The Vanguard Group
Takeda Pharmaceutical Company Limited
UCB S.A

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Inflammatory Bowel Disease Treatment Market

Key Players

Similar Industry Reports